Clinical Trial Update: Lithium Long COVID Dose-finding Study [Phase 1]

View source ↗

Summary

A Phase 1 dose-finding trial evaluating lithium for Long COVID has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-acute Sequelae of Sars-cov-2 Infection

Drugs mentioned

• Lithium carbonate (Lithium carbonate)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Long COVID | Phase 1 | Status: COMPLETED